129 related articles for article (PubMed ID: 1359571)
21. Differential effects of dopamine and AMPA receptor antagonists on the expression of conditioned avoidance responding in rats.
Boivin GA; Beninger RJ
Behav Neurosci; 2008 Apr; 122(2):377-84. PubMed ID: 18410176
[TBL] [Abstract][Full Text] [Related]
22. Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.
Russig H; Kovacevic A; Murphy CA; Feldon J
Psychopharmacology (Berl); 2003 Nov; 170(3):263-270. PubMed ID: 12898122
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases.
Li M; Parkes J; Fletcher PJ; Kapur S
Pharmacol Biochem Behav; 2004 Aug; 78(4):811-9. PubMed ID: 15301940
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of clozapine, metoclopramide, haloperidol and risperidone on acquisition and performance of operant responding in rats.
Baker TW; Florczynski MM; Beninger RJ
Psychopharmacology (Berl); 2015 May; 232(9):1535-43. PubMed ID: 25381749
[TBL] [Abstract][Full Text] [Related]
25. Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism.
Mead A; Li M
J Psychopharmacol; 2010 Jul; 24(7):1045-53. PubMed ID: 19329544
[TBL] [Abstract][Full Text] [Related]
26. An investigation of the behavioral mechanisms of antipsychotic action using a drug-drug conditioning paradigm.
Li M; He W; Mead A
Behav Pharmacol; 2009 Mar; 20(2):184-94. PubMed ID: 19322074
[TBL] [Abstract][Full Text] [Related]
27. Effects of antipsychotic drugs on 5-HT2 receptors in the medial prefrontal cortex: microiontophoretic studies.
Ashby CR; Wang RY
Brain Res; 1990 Jan; 506(2):346-8. PubMed ID: 1967969
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
Skuza G; Rogóz Z; Wieczorek A
Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
[TBL] [Abstract][Full Text] [Related]
29. Effects of centrally acting beta adrenergic agonists on discrete trial conditioned avoidance behavior in rats.
McElroy JF; Stimmel JJ; O'Donnell JM
Psychopharmacology (Berl); 1989; 97(1):108-14. PubMed ID: 2565587
[TBL] [Abstract][Full Text] [Related]
30. Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine.
Ashby DM; Lapish CC; Phillips AG
Behav Pharmacol; 2015 Feb; 26(1-2):133-8. PubMed ID: 25325293
[TBL] [Abstract][Full Text] [Related]
31. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
[TBL] [Abstract][Full Text] [Related]
32. Tolerance to the anti-avoidance properties of cholecystokinin-octapeptide.
Cohen SL; Knight M; Tamminga CA; Chase TN
Peptides; 1983; 4(1):67-70. PubMed ID: 6306617
[TBL] [Abstract][Full Text] [Related]
33. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
Minabe Y; Ashby CR; Wang RY
Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
[TBL] [Abstract][Full Text] [Related]
34. A comparison between a new antipsychotic screening technique (shelf jump avoidance) and a classical discriminative avoidance paradigm.
Herman RL; Malick JB; Kubena RK
Commun Psychopharmacol; 1979; 3(3):165-71. PubMed ID: 40728
[No Abstract] [Full Text] [Related]
35. Different inhibition of conditioned avoidance response by clozapine and DA D1 and D2 antagonists in male mice.
Aguilar MA; Marí-Sanmillán MI; Morant-Deusa JJ; Miñarro J
Behav Neurosci; 2000 Apr; 114(2):389-400. PubMed ID: 10832799
[TBL] [Abstract][Full Text] [Related]
36. Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.
Ding X; Li X; Shu Q; Wu R; Hu G; Li M
Behav Brain Res; 2017 Jun; 328():186-194. PubMed ID: 28412306
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of haloperidol and clozapine on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain.
Dwivedi Y; Rizavi HS; Pandey GN
J Pharmacol Exp Ther; 2002 Apr; 301(1):197-209. PubMed ID: 11907174
[TBL] [Abstract][Full Text] [Related]
38. Discriminative stimulus properties of the typical antipsychotic haloperidol compared to other antipsychotic drugs in C57BL/6 mice.
Donahue TJ; Webster KA; Hillhouse TM; De Oliveira EO; Porter JH
Behav Pharmacol; 2019 Sep; 30(6):521-528. PubMed ID: 31058657
[TBL] [Abstract][Full Text] [Related]
39. Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses.
Kuribara H; Tadokoro S
Pharmacol Biochem Behav; 1981 Feb; 14(2):181-92. PubMed ID: 6111088
[TBL] [Abstract][Full Text] [Related]
40. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
Rothblat DS; Schneider JS
Neurosci Lett; 1997 Jun; 228(2):119-22. PubMed ID: 9209113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
